Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: cancer and CNS disorder therapeutics - Angiochem

Drug Profile

Research programme: cancer and CNS disorder therapeutics - Angiochem

Alternative Names: ANG 3201; ANG-1007; ANG-1009; ANG-1011; ANG-2002; ANG-2004; ANG-2008; ANG-3101; ANG-3202; ANG-4043; Angiopep-antibody-drug conjugate - Angiochem

Latest Information Update: 04 Nov 2017

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator AngioChem
  • Class Drug conjugates; Monoclonal antibodies; Peptides; Small molecules
  • Mechanism of Action Brain derived neurotrophic factor modulators; DNA intercalators; ERBB 2 receptor antagonists; Glucagon like peptide 1 receptor agonists; Immunomodulators; Leptin receptor modulators; Neurotensin receptor modulators; Type II DNA topoisomerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Research Cancer
  • No development reported Brain metastases; Pain
  • Discontinued Brain cancer; Diabetes mellitus; Neurological disorders; Obesity; Parkinson's disease

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Brain metastases in Canada (IV, Injection)
  • 04 Nov 2017 No recent reports of development identified for preclinical development in Pain in Canada
  • 08 Sep 2016 Early research in Cancer in Canada (Parenteral) before September 2016 (Angiochem Pipeline, September 2016)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top